Figure 3From: The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) salineNumber of subjects with a 15% fall in FEV1 to mannitol at each dose interval.Back to article page